IL6 and hepatocellular carcinoma: Additionally, the variant rs2267401 has been shown to increase gallbladder cancer and hepatocellular carcinoma risk, likely by increased APOBEC3B expression that arises through heightened promoter activity and IL-6 response [43, 86].